| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,583,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,917,000 |
Avg
Vol: |
897,586 |
| 52
Week Range: |
$259.55 - $259.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Outten Matthew |
VP, Commercial OperationsOffic |
• – – |
2014-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,554 |
|
- |
|
| Fardis Maria |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
S |
$140.50 |
$421,504 |
D/D |
(3,000) |
2,988 |
|
- |
|
| Fardis Maria |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
5,988 |
|
- |
|
| Hemmi Gregory |
Sr. VP Chemical Operations |
• – – |
2014-03-05 |
4 |
S |
$140.00 |
$2,100,033 |
D/D |
(15,000) |
38,004 |
|
- |
|
| Hemmi Gregory |
Sr. VP Chemical Operations |
• – – |
2014-03-05 |
4 |
OE |
$0.86 |
$12,900 |
D/D |
15,000 |
53,004 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-03-05 |
4 |
S |
$139.66 |
$916,599 |
D/D |
(6,563) |
0 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-03-05 |
4 |
OE |
$25.33 |
$166,241 |
D/D |
6,563 |
6,563 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-03-05 |
4 |
S |
$140.75 |
$880,115 |
D/D |
(6,253) |
1,739 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-03-05 |
4 |
OE |
$25.94 |
$162,203 |
D/D |
6,253 |
7,992 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-03-04 |
4 |
S |
$137.07 |
$1,884,330 |
D/D |
(13,747) |
1,739 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-03-04 |
4 |
OE |
$25.94 |
$356,597 |
D/D |
13,747 |
15,486 |
|
- |
|
| Halvorson Eric H |
Director |
– • – |
2014-03-04 |
4 |
S |
$138.33 |
$480,282 |
D/D |
(3,472) |
1,000 |
|
- |
|
| Halvorson Eric H |
Director |
– • – |
2014-03-04 |
4 |
OE |
$14.26 |
$61,332 |
D/D |
3,472 |
4,472 |
|
- |
|
| Chang Betty Y |
VP, Research/Biology |
• – – |
2014-03-04 |
4 |
S |
$137.97 |
$2,414,484 |
D/D |
(17,500) |
3,754 |
|
- |
|
| Chang Betty Y |
VP, Research/Biology |
• – – |
2014-03-04 |
4 |
OE |
$7.69 |
$179,238 |
D/D |
17,500 |
21,254 |
|
- |
|
| Van Den Broek Richard |
Director |
– • – |
2014-02-27 |
4 |
S |
$144.92 |
$3,622,990 |
I/I |
(25,000) |
29,610 |
|
- |
|
| Van Den Broek Richard |
Director |
– • – |
2014-02-26 |
4 |
S |
$147.13 |
$3,778,170 |
I/I |
(25,680) |
54,610 |
|
- |
|
| Van Den Broek Richard |
Director |
– • – |
2014-02-25 |
4 |
S |
$147.70 |
$4,158,496 |
I/I |
(28,155) |
80,290 |
|
- |
|
| Soni Manmeet Singh |
Chief Financial Officer |
• – – |
2014-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
32,406 |
|
- |
|
| Duggan Robert W |
Chairman and CEO |
• • • |
2013-12-30 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,290 |
30,312 |
|
- |
|
| Duggan Robert W |
Chairman and CEO |
• • • |
2013-12-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,290 |
13,492,378 |
|
- |
|
| Hemmi Gregory |
VP Chemical Operations |
• – – |
2013-12-30 |
4 |
OE |
$0.75 |
$9,750 |
D/D |
13,000 |
38,004 |
|
- |
|
| Tan Heow |
Chief Quality&Tech Operations |
• – – |
2013-12-24 |
4 |
OE |
$27.05 |
$40,575 |
D/D |
1,500 |
1,669 |
|
- |
|
| Duggan Robert W |
Chairman and CEO |
• • • |
2013-12-24 |
5 |
GA |
$0.00 |
$0 |
I/I |
21,438 |
21,438 |
|
- |
|
| Smith David Duane |
Director |
– • – |
2013-12-20 |
4 |
OE |
$1.92 |
$1,920 |
D/D |
1,000 |
3,000 |
|
- |
|
355 Records found
|
|
Page 2 of 15 |
|
|
